Phase III randomized clinical studies to evaluate the immunogenicity, lot-to-lot consistency, and safety of ROTAVAC® liquid formulations (ROTAVAC 5C & 5D) and non-inferiority compa... by Krishna Kumari P, Siddharth Reddy Chiteti, Vinay K. Aileni, Sudhir Babji, William C. Blackwelder, Ashok Kumar, Jayant Vagha, Uma Nayak, Monjori Mitra, Narayanaappa D, Sonali Kar, Sangeeta Yadav, Swamy Naidu, Niranjan Mahantshetti, Vasant Khalatkar, Satyajit Mohapatra, P. K. Purthi, Pawan Sharma, A. Kannan, Ramchandra Keshav Dhongade, Sai D. Prasad, Raches Ella, Krishna Mohan Vadrevu

Get full text